Clandestine Trailer Unveiled PASADENA, Calif., Jan. 13,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Clandestine Trailer Unveiled

PASADENA, Calif., Jan. 13, 2014 (GLOBE NEWSWIRE) -- Thousand Pounds Action Company and their new production unit Epic Rival, together with the support of Ayzenberg Group's Original Content and [ion] (Influencer Outreach Network) divisions, have just released the trailer for the first two episodes of the highly-anticipated Clandestine series.

View Clandestine: First Two Episodes Trailer here.

"We are very excited to release the first Clandestine trailer and show our fans that we've been hard at work bringing our vision to life," said Chris Cowan, Director, Thousand Pounds Action Company. "We're currently in talks with several studios about the series and we're hoping to finally close on a distribution deal sometime in 2014."

Having come to notoriety via the popular Real Life Ultra Combos , Naruto Shippuden: Dreamers Fight and STREET FIGHTER X TEKKEN: The Devil Within videos, Thousand Pounds Action Company and Epic Rival have completed the first two episodes of their full-length action series, Clandestine . In the modern martial arts epic, the classic tension of star-crossed lovers is amplified by the presence of four reigning powers – clans with an ancient rivalry as old as civilization itself – and beliefs rooted in a tradition of warfare.

The concept for the series was announced in 2012 with a Kickstarter campaign which ignited the martial arts community to raise more than $95,000 to see the series developed. Additional production budget came from Ayzenberg Group's Original Content and ION (Influencer Outreach Network) divisions, which Cowan is a member of. This team works with YouTubers to partner them with brands to create unique, original content that launches with a built-in fan base.

"Clandestine was an early test of Ayzenberg's Original Content and ION divisions that are focused on supporting YouTube talent bringing unique content to life that fans want to see," said Eric Ayzenberg, Owner and Chief Creative Officer of Ayzenberg Group. "As an ad agency we're doing increasing amounts of this work and helping brands partner up with these talented content creators in authentic and engaging ways. We're excited to see Clandestine come to life this year."

Just below the façade of modern America, a feudal war as old as civilization is reignited in the wake of a mysterious mass murder. After years of peace, these clans must ready their supernatural gifts for war, and a young woman from the surface world struggles to learn the truth of herself, her family, and her legacy as the matriarch of a clandestine kingdom.

While fans will still have to wait for final series distribution details to be revealed, they can rest assured that Clandestine will not only bring Martial Arts into a respected storytelling platform but it will debut as a genre and style that is unlike anything that has been seen on television and/or web today.

News and updates on Clandestine are shared via their social channels: https://www.facebook.com/ClandestinePath and Facebook.com/ThousandPoundsActionCompany .

About Clandestine

Clandestine is an original martial arts action & drama series created by Epic Rival (The writers & directors of Thousand Pounds Action Co.) that defines a new style for the action medium. Funded by martial arts fans who donated more than $95,000 through Kickstarter, Clandestine will not only bring Martial Arts into a respected storytelling platform but overall it will debut as a genre and style that is unlike anything that has been seen on television and/or web today.

About Epic Rival

Epic Rival's purpose is to bring engaging storytelling and a unique eye to the fantasy/action genre. Our name stands as a challenge to all of the dichotomies we've seen in modern media. Flash versus Substance. Originality versus Marketability. We are here to stand as a rival to mediocrity, to use our creative story-telling and adrenaline pumping action to show people worlds and stories they've never imagined.

About Ayzenberg Group

Founded in 1993 and now one of the ten largest privately held creative firms on the West Coast, Ayzenberg is a full-service advertising agency with a distinctly social and agile approach. We're all about creating and sharing brand stories–in a real-time, always-on, multi-screen way. We have advertising, social media, digital, original content, media planning and implementation, analytics and more under one roof, working as one. From videogame to beverage and consumer electronic brands, our clients value how we target, convert and generate traction with today's connected 'Gen Now' consumers. Current clients include Activision, EA, Microsoft, Red Bull, Sony, Mattel, Yahoo!, Disney, and Warner Bros. Learn more: www.ayzenberg.com .

About [ion]

Founded by Ayzenberg Group in 2013, [ion] is an ever-growing network of YouTubers, Bloggers, and social media trendsetters who are partnered together with brands to deliver original content directly to millions of consumers. Participating influencers spread across industries from gaming and technology to fashion and music. Learn more: InfluencerOutreach.net

For More Information: Eric Ayzenberg | Ayzenberg Group | +1 (626) 584 - 4070

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 397

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 149

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 205

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 606

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 288

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 196

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 245

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 223

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 322

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

Care Synergy and RCC Medical Equipment Launch New Partnership

Updated Category News Views 320

Care Synergy and RCC Medical Equipment Form Joint Venture In an exciting development for healthcare services, Care Synergy and RCC Medical Equipment Co. have announced their plans to create a strategic joint venture aimed at improving healthcare delivery in the Colorado Front Range region. This partnership will leverage the strengths of both organizations to provide...

Continue Reading
Revitalizing China's Tourism with High-Tech Cultural Experiences

Updated Category News Views 217

Revitalizing China's Tourism Through High-Tech Cultural Experiences China's tourism industry is undergoing an exciting transformation, fueled by the innovative use of advanced technology paired with its rich cultural heritage. A remarkable example is in Chongqing Municipality, where the city's skyline has become a vibrant showcase of cultural stories, highlighted by...

Continue Reading
Intriguing Insights into United States Steel Options Trades

Updated Category News Views 111

Analyzing Unusual Options Activity in United States Steel Recently, there's been notable market activity where investors with deep pockets are taking a more bearish stance on United States Steel (X). This trend is definitely something for retail traders to pay attention to, especially when navigating the complexities of the stock market. Today's options history unveiled...

Continue Reading
Mesoblast's Operational Highlights and Financial Insights Unveiled

Updated Category News Views 185

Mesoblast Limited's Webcast for Financial Results On a recent occasion, Mesoblast Limited (NASDAQ: MESO; ASX: MSB), a pioneer in allogeneic cellular medicine for inflammatory diseases, announced a webcast to delve into their operational achievements and financial metrics for the half year concluding December 31, 2024. Details of the Webcast Event The engaging webcast is...

Continue Reading
Investors of DXC Technology Prepare for Class Action Lawsuit

Updated Category News Views 77

Investors of DXC Technology Company Take Action In recent months, investors who purchased common stock from DXC Technology Company (NYSE: DXC) have been given a significant opportunity to participate in a class action lawsuit. This situation arises from allegations of securities fraud that are said to have affected many individuals who bought shares during specific key...

Continue Reading